ICICI Prudential Mutual Fund decreased its stake in FDC Limited from 2.85% to 2.80% by selling 88,077 shares. The value of shares sold is ₹3.70 Cr at ₹420.10 apiece.
A fully integrated pharmaceutical company established in 1936, FDC Limited manufactures specialized formulations and operates as one of the world's foremost producers of Oral Rehydration Salts. The company develops and markets a diverse portfolio of brands including Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zathrin, Zipod, Cotaryl, and Mycoderm across domestic and international markets, focusing on affordable healthcare solutions across multiple therapeutic segments.
India's second-largest AMC by AUM with over Rs 9 lakh crore managed across 80+ schemes. Joint venture between ICICI Bank and Prudential plc. CIO S. Naren is one of India's most recognised value investors, known for contrarian macro calls and rotating across market caps well ahead of consensus. ICICI Pru's quarterly portfolio disclosures are among the most closely watched in the industry.
